Stacey Johnson
Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.
Posts by: Stacey
With 570 stem cell clinics in the United States alone offering direct-to-consumer marketing of stem cell interventions and “clear grounds for concern that some of the companies we found are not compliant with federal regulations” (Knoepfler and Turner, Cell Stem Cell), it comes as little surprise that patients are getting treatments that, at best, do […]
International Women’s Day (IWD), also known as the United Nations (UN) Day for Women’s Rights and International Peace, is an opportunity to honour women’s achievements, “to call for change and to celebrate acts of courage and determination by ordinary women who have played an extraordinary role in the history of their countries and communities.” I […]
Trustees at the Halton Catholic District School Board adopted a motion last week to ban board donations to non-profits or charities that publicly support “either directly or indirectly, abortion, contraception, sterilization, euthanasia, or embryonic stem cell research.” Opposition to embryonic stem cell research is nothing new. In August 2001, American stem cell researchers were greatly […]
If you follow amyotrophic lateral sclerosis (ALS) research, you may be interested to know that ALS Canada is holding a free webinar (registration link enclosed) on February 28 to explain how funds from the ALS #Icebucketchallenge from 2014 were spent. Do you remember the #Icebucketchallenge? Of course you do! It was a social media campaign […]
Cell and Gene Therapy World, or “Phacilitate” as delegates like to refer to it, happened last week in Miami, Florida (January 22-25). The conference, with 1,500 in attendance, brings together industry professionals from more than 30 countries. The event explores trends and opportunities that are shaping the future of cell and gene therapies (CGTs). […]
Right Turn: Will civil lawsuits stop the marketing of unapproved stem cell treatments?
With 570 stem cell clinics in the United States alone offering direct-to-consumer marketing of stem cell interventions and “clear grounds for concern that some of the companies we found are not compliant with federal regulations” (Knoepfler and Turner, Cell Stem Cell), it comes as little surprise that patients are getting treatments that, at best, do […]